Evaluation Of The Results Of Simultaneous Pancreatic And Hepatic Resections For Metastatic Neuroendocrine Tumors.

Study Overview

Evaluation of the Results of Simultaneous Pancreatic and Hepatic Resections for Metastatic Neuroendocrine Tumors.

The indications for synchronous liver resection for metastatic neuroendocrine tumors of pancreatic origin remain debated and poorly described in the literature. The reported mortality of this type of simultaneous resection remains very high, especially when a cephalic duodenopancreatectomy is associated with a hepatic resection (up to 40%). The benefit in terms of survival remains to be evaluated. The ReSiPaTNE study proposes to create a retrospective cohort of simultaneous pancreatic and hepatic resections for metastatic neuroendocrine tumors in order to evaluate the short and long term results of this type of resection. The evaluation of the results of this type of resection may be useful for the selection of patients for treatment.

N/A

Tumor of Pancreas

8511

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates	Results Reporting Dates	Study Record Updates
First Submitted 2022-08-29	Results First Submitted N/A	Last Update Submitted that met QC Criteria 2023-11-07
First Submitted that Met QC Criteria 2022-09-01	Results First Submitted that Met QC Criteria N/A	Last Update Posted (ACTUAL) 2023-11-08
First Posted (ACTUAL) 2022-09-06	Results First Posted N/A	Last Verified 2022-08

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A

Allocation:
N/A

Interventional Model:
N/A

Masking:
N/A

Arms and Interventions

Participant Group/Arm	Intervention/Treatment

Primary Outcome Measures	Measure Description	Time Frame
Postoperative morbidity and mortality of simultaneous pancreatic and hepatic resectio		Morbidity and mortality at 90 postoperative days

Secondary Outcome Measures	Measure Description	Time Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

Major subjects (≥18 years old)
Subject having had a first pancreatic resection for NET with resections of synchronous metastases
Subject having had a first pancreatic resection for NET followed by a delayed resection of synchronous metastases
Subject who has not expressed his opposition, after being informed, to the reuse of his data for the purposes of this research

Subject who expressed their opposition to participating in the study
Pregnant women
Subject under safeguard of justice
Subjects under guardianship or curatorship

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

PRINCIPAL_INVESTIGATOR: Pietro ADDEO, MD, Service de Chirurgie Générale, Hépatique, Endocrinienne et Transplantation - CHU de Strasbourg - France

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available

Learn

Resources

PatientS

Caregivers

Clinical Trial Record